Eli Lilly played down risks of top drug-NY Times
605613
Drug giant Eli Lilly has engaged in a  decade-long effort to play down the health risks of its  top-selling medication, the schizophrenia drug Zyprexa, The New  York Times reported in Sunday editions.
403607
THE pharmaceutical industry was reeling last night, as AstraZeneca and Pfizer put key drug development programmes on hold and Eli Lilly issued a warning on one of its best selling medicines.
432135
The Food and Drug Administration yesterday approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
695576
Eli Lilly loses a pair of patent cases over its top compound.
669191
Eli Lilly and Co. has downplayed for about 10 years the risks associated with Zyprexa, which treats schizophrenia, The New York Times said on its Web site Sunday, citing internal documents from the drug maker and e-mail messages of its managers.
624263
Eli Lilly and Co LLY.N said Friday  it added a warning to the label of its attention  deficit/hyperactivity disorder medicine, advising patients with  jaundice or a liver injury to stop taking the treatment.
667642
In a surprising setback for the  world's largest drugmaker, Pfizer Inc.  halted  development on Saturday of its top experimental medicine, the  cholesterol drug torcetrapib, due to safety concerns.
416973
Eli Lilly and Co. on Friday said it added a warning to the label of its attention deficit/hyperactivity disorder medicine, advising patients with jaundice or a liver injury to stop taking the treatment.
443779
Investors in pharmaceuticals were dealt a triple whammy on Friday as Pfizer Inc, AstraZeneca Plc and Eli Lilly and Co all shocked the market with bad news about key products.
515541
INDIANAPOLIS, July 24  â Eli Lilly, with help from its core medicines Zyprexa and Cymbalta, beat Wall Streetâs second-quarter expectations Tuesday, although profits fell 19 percent at the pharmaceutical company because of acquisition costs.
105288
WASHINGTON -- The Food and Drug Administration yesterday approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
131141
Eli Lilly said it stopped giving its most-watched experimental medicine, the blood-clot preventer prasugrel, to patients in two small trials.
216500
Eli Lilly and Co. on Thursday said one of its experimental drugs was comparably effective in a mid-stage trial as the company's widely used Zyprexa treatment, but without weight gains seen with Zyprexa.
763482
Investors are likely to question why Lilly is still fiddling with the dosage of prasugrel.
270216
The Food and Drug Administration reportedly is reviewing internal Eli Lilly documents that suggest the anti-depressant Prozac may be linked to violent behavior.
388672
Eli Lilly & Co  said on Friday that it had won approval to market its blockbuster osteoporosis drug to post-menopausal women who are at high risk for invasive breast cancer.
287117
Drug company Eli Lilly  has encouraged primary care physicians to use Zyprexa, a powerful drug for schizophrenia and bipolar disorder, in patients who did not have either condition, the New York Times reported on its Web site on Monday, citing internal Lilly marketing materials.